1. --Harshal Rajekar 2. ….Why? We do see many a patient with recurrent hepato-cellular cancer after liver resection. Especially in the setting of a chronic Liver…

Slide 1Novel Targeted Drugs and Their Introduction to the Clinic Phil Bedard MD, FRCP(C) Division of Medical Oncology/Hematology Drug Development Program Slide 2 Learning…

Slide 1Ten Years Longitudinal Follow-up Study of Sickle Cell Disease Patients Treated with Hydroxyurea in Four English Centres 20 th September 2007 Annette Gilmore RN BSc…

1. Prolactin Screening in a Cohort ofSchizophrenia Patients in Small Heath, Birmingham Dr Imran Waheed Consultant in Adult Psychiatry 24 thFebruary 2009 2. Aims To establish…

1. Inspiring Innovationin Australian Healthcare“ The best way to predict the future is to invent it” Alan Kay 2. About the 2014 HaTCH ChallengeJanssen wants you to help…

1. Cemented or non-cemented fixation: an issue? David Beverland Belfast N Ireland PROGRAM VOCA LUSTRUM CONGRESS KNEE ARTHROPLASTY SEPTEMBER 15 th– HUIS TER DUIN – NOORDWIJK…

1. Cemented or non-cemented fixation: an issue? David Beverland Belfast N Ireland PROGRAM VOCA LUSTRUM CONGRESS KNEE ARTHROPLASTY SEPTEMBER 15 th– HUIS TER DUIN – NOORDWIJK…

1. John Skerritt, National Manager Pharmaceutical Law Conference May 2014 An update from the Medicines Regulator: Managing and Communicating Risk and Strengthening International…

1. Anne-Maree KellyDirector, Joseph Epstein Centre for Emergency MedicineResearch@Western Health, Melbourne@kellyam_jec 2.  This presentation may be reproduced in part…

1. Preparing for the Future ‘Towards 2026’:A new Community Service model at MaryPotter HospiceTeresa Read, Enhanced Community Services Project ManagerTanya Loveard, Allied…